stockrow
Friday 6 November 2026
Export AHG’s income statement to Excel — free account
Akso Health Group Sponsored ADR
AHG Healthcare Medical Distribution
Akso Health Group Sponsored ADR’s revenue for fiscal 2026 (year ended March 2026) was $13.8 million, down 6.40% from fiscal 2025.
1.30
0.03
−2.26%
Follow AHG
Alert me
| Sep '25 | Sep '24 | Sep '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | (99.22%) | (139.96%) |
+8 more TTM periods Free account |
|
| 0.00% | 0.00% | (49.98%) | (69.78%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | (231.55%) | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 105.61 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(160.20) | 13.50 | (12.44) | (11.88) | |
Capital Expenditures |
(177.19) | (1.59) | — | — | |
| Other line items | |||||
Cash ROIC |
(76.49%) | 4.55% | (85.51%) | (71.34%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 1.57 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
— | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | |
Operating CF/Net income |
0.00 | 0.00 | 1.01 | 0.65 | |
Depreciation/Fixed assets |
88.94 | 1.44 | — | — | |
Capex/Depreciation |
(129.37) | (9.70) | — | — | |
Revenue per Share |
— | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026